Chris Doering is an associate professor of Pediatrics at Emory University and the co-founder of Expression Therapeutics LLC. His research interests center upon using the application of gene therapy and therapeutic protein bioengineering technologies to treat pediatric bleeding disorders and cancers.
http://biomed.emory.edu/PROGRAM_SITES/MSP/guides/faculty-detail.html?action=getFacultyDetail&gdbbsId=27818675-1df5-43e9-abab-0b93d3709a1a
